ClinConnect ClinConnect Logo
Search / Trial NCT06066307

Olfactory Performance in Culinary Arts Students

Launched by LEIGH SOWERBY · Sep 27, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Olfactory Training Olfaction Smell Hyposmia Anosmia Olfactory Disfunction

ClinConnect Summary

This clinical trial is studying how cooking and the smells associated with it can help improve the sense of smell in people who have experienced a loss of smell, particularly after COVID-19. The researchers want to see if culinary training can be as effective, or even more effective, than traditional olfactory training (OT), which is a therapy that involves smelling specific scents repeatedly over several weeks. The study will involve students from a culinary arts program at Fanshawe College, who will be tested for their sense of smell, along with students from a different program for comparison.

To participate, you need to be at least 18 years old, enrolled in one of these programs, and able to read and write in English. You also need to be able to give your consent to be part of the study. However, if you have a history of complete loss of smell (anosmia) or chronic sinus issues, you won’t be eligible. If you join, you can expect to take part in olfactory tests and potentially benefit from the smells encountered during cooking, which may be more relatable and enjoyable than traditional scent training. Overall, this trial aims to explore a new approach to help those struggling with their sense of smell.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age 18 years or older
  • enrolled in an introductory training program at Fanshawe collage (Culinary arts or Information Technology)
  • capable of providing informed written consent
  • capable of reading and writing in English
  • Exclusion Criteria:
  • Participants with a history of anosmia, and chronic sinus disease.

About Leigh Sowerby

Leigh Sowerby is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in the pharmaceutical and biotechnology sectors, Sowerby focuses on innovative therapeutic solutions across various disease areas. By fostering collaboration between researchers, healthcare professionals, and regulatory bodies, he ensures the efficient and ethical conduct of clinical trials. His leadership emphasizes transparency, patient safety, and adherence to regulatory standards, positioning him as a trusted partner in the development of groundbreaking treatments.

Locations

London, Ontario, Canada

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported